Boston Scientific (BSX) Competitors

Boston Scientific (NYSE:BSX) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, community ranking, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk.

Which has preferable valuation and earnings, BSX or ABT?

Abbott Laboratories has higher revenue and earnings than Boston Scientific. Abbott Laboratories is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$14.24B	9.33	$1.59B	$1.21	74.52
Abbott Laboratories	$41.22B	4.88	$5.72B	$3.29	35.24

Does the MarketBeat Community favor BSX or ABT?

Boston Scientific received 103 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 69.70% of users gave Abbott Laboratories an outperform vote while only 69.60% of users gave Boston Scientific an outperform vote.

Company	Underperform	Outperform
Boston Scientific	Outperform Votes 1037 69.60%	Underperform Votes 453 30.40%
Abbott Laboratories	Outperform Votes 934 69.70%	Underperform Votes 406 30.30%

Is BSX or ABT more profitable?

Abbott Laboratories has a net margin of 13.99% compared to Boston Scientific's net margin of 11.26%. Abbott Laboratories' return on equity of 20.18% beat Boston Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	11.26%	17.23%	9.52%
Abbott Laboratories	13.99%	20.18%	10.84%

Which has more volatility and risk, BSX or ABT?

Boston Scientific has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500.

Do insiders and institutionals have more ownership in BSX or ABT?

89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.5% of Boston Scientific shares are held by insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Does the media prefer BSX or ABT?

In the previous week, Boston Scientific and Boston Scientific both had 42 articles in the media. Abbott Laboratories' average media sentiment score of 1.50 beat Boston Scientific's score of 0.87 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	27 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Abbott Laboratories	39 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate BSX or ABT?

Boston Scientific presently has a consensus target price of $93.39, suggesting a potential upside of 3.57%. Abbott Laboratories has a consensus target price of $130.07, suggesting a potential upside of 12.19%. Given Abbott Laboratories' higher possible upside, analysts plainly believe Abbott Laboratories is more favorable than Boston Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	0 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.91
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.75

Summary

Boston Scientific and Abbott Laboratories tied by winning 9 of the 18 factors compared between the two stocks.